Which of the following is a contraindication for medical management of gallstones
**Core Concept**
The medical management of gallstones involves dissolving cholesterol stones using ursodeoxycholic acid (UDCA) or a combination of UDCA and ursodiol. However, this treatment approach is not suitable for all patients, particularly those with specific underlying conditions that may contraindicate its use.
**Why the Correct Answer is Right**
One such contraindication is **gallbladder cancer**. The presence of gallbladder cancer is a contraindication for medical management of gallstones because cancer cells can grow and metastasize during the treatment period, making it less effective and potentially life-threatening. Furthermore, the underlying pathophysiology of gallbladder cancer involves chronic inflammation and scarring, which may not respond well to medical dissolution therapy.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because **chronic cholecystitis** is actually a condition that may benefit from medical management of gallstones, particularly if the patient has a high risk of gallstone recurrence or surgery is contraindicated.
* **Option B:** This option is incorrect because **cholesterol stones** are the primary target for medical management using UDCA or ursodiol, making it not a contraindication but rather an indication for treatment.
* **Option C:** This option is incorrect because **primary biliary cirrhosis** is a condition that may be treated with ursodeoxycholic acid (UDCA), actually making it a potential indication for medical management rather than a contraindication.
**Clinical Pearl / High-Yield Fact**
It is essential to note that medical management of gallstones is generally reserved for patients with high-risk conditions, such as **porcelain gallbladder**, where surgery is contraindicated or carries a high risk of complications.
**Correct Answer:** D.